Ascendis Pharma A/S (ASND)
NASDAQ: ASND · IEX Real-Time Price · USD
+1.78 (1.47%)
May 21, 2024, 4:00 PM EDT - Market closed

Ascendis Pharma Statistics

Total Valuation

ASND has a market cap or net worth of $6.96 billion. The enterprise value is $7.33 billion.

Market Cap 6.96B
Enterprise Value 7.33B

Important Dates

The last earnings date was Thursday, May 2, 2024, after market close.

Earnings Date May 2, 2024
Ex-Dividend Date n/a

Share Statistics

ASND has 56.61 million shares outstanding.

Shares Outstanding 56.61M
Owned by Insiders (%) 0.76%
Owned by Institutions (%) 107.45%
Float n/a

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 19.45
Forward PS 12.87
PB Ratio n/a
P/FCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales 20.51
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 0.83

Current Ratio 0.83
Quick Ratio 0.49
Debt / Equity n/a
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage -3.13

Financial Efficiency

Return on Equity (ROE) n/a
Return on Assets (ROA) -60.30%
Return on Capital (ROIC) -83.79%
Revenue Per Employee $406,864
Profits Per Employee -$620,232
Employee Count 879
Asset Turnover 0.40
Inventory Turnover 0.25


In the past 12 months, ASND has paid $9.24 million in taxes.

Income Tax 9.24M
Effective Tax Rate n/a

Stock Price Statistics

The stock price has increased by +36.27% in the last 52 weeks. The beta is 0.53, so ASND's price volatility has been lower than the market average.

Beta (1Y) 0.53
52-Week Price Change +36.27%
50-Day Moving Average 141.52
200-Day Moving Average 119.45
Relative Strength Index (RSI) 29.82
Average Volume (30 Days) 351,472

Short Selling Information

Short Interest 3.70M
Short Previous Month 3.60M
Short % of Shares Out 9.41%
Short % of Float n/a
Short Ratio (days to cover) 12.42

Income Statement

In the last 12 months, ASND had revenue of $357.63 million and -$545.18 million in losses. Loss per share was -$9.63.

Revenue 357.63M
Gross Profit 305.83M
Operating Income -391.95M
Pretax Income -535.33M
Net Income -545.18M
EBITDA -385.19M
EBIT -405.65M
Loss Per Share -$9.63
Full Income Statement

Balance Sheet

The company has $347.70 million in cash and $726.38 million in debt, giving a net cash position of -$378.68 million or -$6.69 per share.

Cash & Cash Equivalents 347.70M
Total Debt 726.38M
Net Cash -378.68M
Net Cash Per Share -$6.69
Equity / Book Value -258.60M
Book Value Per Share -4.57
Working Capital -146.42M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$458.07 million and capital expenditures -$1.63 million, giving a free cash flow of -$459.71 million.

Operating Cash Flow -458.07M
Capital Expenditures -1.63M
Free Cash Flow -459.71M
FCF Per Share -$8.08
Full Cash Flow Statement


Gross margin is 85.52%, with operating and profit margins of -109.60% and -152.44%.

Gross Margin 85.52%
Operating Margin -109.60%
Pretax Margin -149.69%
Profit Margin -152.44%
EBITDA Margin -107.71%
EBIT Margin -113.43%
FCF Margin -128.54%

Dividends & Yields

ASND does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -1.41%
Shareholder Yield -1.41%
Earnings Yield -7.84%
FCF Yield -6.61%
Dividend Details

Analyst Forecast

The average price target for ASND is $173.88, which is 41.54% higher than the current price. The consensus rating is "Buy".

Price Target $173.88
Price Target Difference 41.54%
Analyst Consensus Buy
Analyst Count 8
Revenue Growth Forecast (5Y) 60.03%
EPS Growth Forecast (5Y) n/a
Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a


ASND has an Altman Z-Score of 1.94 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score 1.94
Piotroski F-Score 3